LeonaBio, Inc. Capital Expenditures Incurred but Not yet Paid
LeonaBio, Inc. (LONA) reported Capital Expenditures Incurred but Not yet Paid of $6.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2022-05-12
- LeonaBio, Inc. capital expenditures incurred but not yet paid for the quarter ending 2022-03-31 was $6.00K, a 89.47% decline year-over-year.
- LeonaBio, Inc. capital expenditures incurred but not yet paid for the quarter ending 2021-12-31 was -$205.00K.
- LeonaBio, Inc. capital expenditures incurred but not yet paid for the quarter ending 2021-03-31 was $57.00K.
- LeonaBio, Inc. capital expenditures incurred but not yet paid for the quarter ending 2020-12-31 was -$609.00K.
- LeonaBio, Inc. capital expenditures incurred but not yet paid for fiscal 2021 was $14.00K, a 95.77% decline from fiscal 2020.
- LeonaBio, Inc. capital expenditures incurred but not yet paid for fiscal 2020 was $331.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2022-03-31 | $6.00K 10-Q · filed 2022-05-12 | -$199.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2021-12-31 | -$205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $14.00K 10-K · filed 2022-03-28 | ||
| 2021-09-30 | $219.00K 10-Q · filed 2021-11-10 | |||
| 2021-03-31 | $57.00K 10-Q · filed 2022-05-12 | -$552.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$609.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $331.00K 10-K · filed 2022-03-28 | ||
| 2020-09-30 | $940.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |